Aims/hypothesis. Glutamate dehydrogenase (GDH) is a mitochondrial enzyme playing a key role in the control of insulin secretion. However, it is not known whether GDH expression levels in beta cells are ratelimiting for the secretory response to glucose. GDH also controls glutamine and glutamate oxidative metabolism, which is only weak in islets if GDH is not allosterically activated by L-leucine or (+/−)-2-aminobicyclo-[2,2,1]heptane-2-carboxylic acid (BCH). Methods. We constructed an adenovirus encoding for GDH to overexpress the enzyme in the beta-cell line INS-1E, as well as in isolated rat and mouse pancreatic islets. The secretory responses to glucose and glutamine were studied in static and perifusion experiments. Amino acid concentrations and metabolic parameters were measured in parallel.
Glutamate dehydrogenase (GDH; EC 1.4.1.3), encoded by GLUD1 [1] , is a homohexamer located in the mitochondrial matrix. GDH catalyses the reversible reaction α-ketoglutarate + NH 3 + NAD(P)H ↔ glutamate + NAD(P) + [2] . In the brain, this enzyme ensures the cycling of the neurotransmitter glutamate to glutamine between neurons and astrocytes [3] . GDH also plays a major role in ammonia metabolism and detoxification, mainly in the liver and the kidney [4] . In the pancreatic beta cells, the importance of GDH as a key enzyme in the control of insulin secretion was recognised long ago [5] . Inhibition of its activity was shown to decrease insulin release [6] as well as glutamate concentrations [7] . Conversely, activating mutations of GDH have been associated with a hyperinsulinism syndrome [8, 9] . The enzyme is allosterically regulat-ed by leucine, pyridine, adenine and guanine nucleotides [10, 11] . Reduced GTP-mediated inhibition of the enzyme was associated with most GDH mutations linked to the hyperinsulinism syndrome [12] . The importance of GDH, and the related glutamate pathway in general, is also highlighted by debate on the role of glutamate as an intracellular messenger in glucosestimulated insulin exocytosis [13, 14, 15, 16, 17, 18] .
In pancreatic beta cells, the increase of cytosolic Ca 2+ levels is necessary to elicit insulin exocytosis, although it does not account for the full effect of glucose [19] . Primarily, mitochondria fulfill the pivotal function of generating signals coupling glucose sensing to insulin secretion [20] . Mitochondrial metabolism generates ATP, which promotes the closure of ATP-sensitive K + channels [21] and, as a consequence, the depolarisation of the plasma membrane [22] . This leads to Ca 2+ influx through voltage-gated Ca 2+ channels and a rise in cytosolic Ca 2+ triggering insulin exocytosis [23] . Then, additive signals are generated by glucose and contribute to the sustained phase of insulin release [19] .
Unlike glucose, glutamine is not efficiently processed through oxidative metabolism in beta cells and, as a result, does not stimulate insulin release on its own [24, 25] . Probably, only a small fraction of the total GDH flux is used under normal conditions [26] , because of the important allosteric control of this enzyme. Indeed, glutamine oxidation can be prompted by allosteric activation of GDH, an effect correlating with stimulation of insulin secretion [25, 27] . However, glucose exposure inhibits glutamine oxidation [28] and glutamate formation from glutamine [29] . Therefore, GDH could play a dual role in glutamate handling [30] . On the one hand, this could be a cataplerotic role when glutamate is produced as a glucose-derived factor [31] implicated in the stimulation of insulin exocytosis. On the other hand, it could be an anaplerotic role when glutamate serves as a mitochondrial substrate feeding the tricarboxylic acid (TCA) cycle. Taken together, these modes of action point to GDH as a major regulatory enzyme for the control of insulin secretion.
Several studies have reported the effects of GDH allosteric regulation on insulin release [32, 33] . In our study we investigated combined alterations of GDH expression with allosteric regulation of the enzyme. GDH was overexpressed in the beta cell line INS-1E, as well as in isolated pancreatic islets of rat and mouse origin. In these conditions, responses to glucose, the main insulin secretagogue, as well as to glutamine were tested.
Materials and methods
Cell culture. Adenovirus amplification was done in HEK-293 cells cultured in DMEM medium with 10% fetal calf serum.
The clonal beta cell line INS-1E [34] , derived from parental INS-1 cells [35] , was cultured in Roswell Park Memorial Institute (RPMI) 1640 medium with 5% fetal calf serum. Adherent cultured INS-1E cells were infected with recombinant adenovirus for 90 min at 37°C, washed once, and further cultured in complete RPMI-1640 medium for 18 to 20 h before experiments.
Animals. Wistar rats or BALB/c mice weighing 200 to 250 g and 25 to 30 g respectively were obtained from in-house breeding (CMU-Zootechnie, Geneva, Switzerland). We followed the principles of laboratory animal care and the study was approved by the responsible ethics committee. Pancreatic islets were isolated by collagenase digestion from male Wistar rats or BALB/c mice as described previously [36] . Isolated islets were cultured free-floating in RPMI-1640 medium for 24 h before adenovirus transduction.
Adenovirus construction. Recombinant adenovirus encoding human GLUD1 under the chicken actin promoter [37] was generated as described previously [15, 38] . The plasmid hGLUD1-pcDNA3 containing full-length human GLUD1 cDNA [8] was kindly provided by Dr C.A. Stanley and Dr B.Y. Hsu (The Children's Hospital of Philadelphia, Philadelphia, Pa., USA). Following PstI digestion, the insert with blunt ends was sub-cloned in a cosmid pAdCAG [38] , previously opened by SwaI. The presence and right orientation of the insert were checked by restriction enzyme digestions using ClaI and BglII (Invitrogen, La Jolla, Calif., USA). The cosmid containing hGLUD1 (pAd-CAG-hGLUD1) and the adenovirus type 5 DNA terminal protein complex (DNA-TPC) were cotransfected using calcium phosphate (CellPhect, Amersham Pharmacia, Piscataway, N.J., USA) in HEK-293 cells, which were seeded in 96-well plates. Ten days after transfection the cell lysate was used to infect 24-well plates, the adenoviral DNA was extracted from the cells and analysed by DNA digestion with ClaI and XhoI to check for the presence of hGLUD1. The cell lysate containing the virus with full-length hGLUD1 (AdCA-hGLUD1) was used to infect two 138-mm dishes of HEK-293 cells. The virus was purified by CsCl ultracentrifugation (L8-70M, Beckman Coulter, Fullerton, Calif., USA) and referred to as Ad-GDH. AdCA-lacZ, which expresses bacterial β-galactosidase, was used as a control adenovirus (Ad-LacZ).
Transductions were done by infection of INS-1E cells or rodent islets with 1.0 µl of purified virus per ml of media (unless otherwise stated) for 90 min, corresponding to approximately 40 PFU/cell.
Immunoblotting, GDH activity, and immunofluorescence. SDSPAGEs were run using 5 µg protein of INS-1E cell or islet extracts [39] per lane or standard of purified bovine GDH (Roche Diagnostics, Rotkreuz, Switzerland) on 11% gel. Proteins were transferred on to nitrocellulose membrane and incubated overnight at 4°C in the presence of rabbit anti-GDH polyclonal antibody (1:5000) raised against bovine GDH (Rockland, Gilbertsville, Pa., USA). The membrane was then incubated for 1 h at room temperature with donkey anti-rabbit IgG antibody (1:5000) conjugated to horseradish peroxidase (ECL, Amersham, Zürich, Switzerland), and the GDH protein was revealed by chemiluminescence (Pierce, Rockford, Ill., USA).
GDH activity was measured from cell extracts of transduced INS-1E cells lysed in 20 mmol/l Tris-HCl pH 8.0, 2 mmol/l CDTA and 0.2% Tween-20. GDH activity was monitored under the oxidative deamination direction as NADH fluorescence excited at 340 nm and measured at 460 nm in 1.5 ml buffer (50 mmol/l Tris-HCl pH 9.5, 2.6 mmol/l EDTA, 1.4 mmol/l NAD, 1 mmol/l ADP) using an LS-50B fluorimeter (Perkin-Elmer, Bucks, UK). After a 5-min equilibration period, the addition of 1 mmol/l L-glutamate started the reaction and 20 min later an excess of purified bovine GDH was added as control.
For immunofluorescence, cells were grown on polyornithine-treated glass coverslips for 3 days prior to infection with Ad-LacZ or Ad-GDH for 90 min. The next day cells were loaded with 100 nmol/l mitotracker (Molecular Probes, Leiden, The Netherlands) for 25 min at 37°C to stain mitochondria. Then cells were fixed as described [40] before incubation with anti-GDH (1:1000, Rockland) and then goat anti-rabbit IgG fluorescein (1:500) antibodies (Chemicon, Temecula, Calif., USA). Cells were viewed using a Zeiss laserscan confocal 410 microscope (Carl Zeiss, Göttingen, Germany).
Measurement of amino acid levels. INS-1E cells were cultured for 2 to 3 days in six-well plates, infected with Ad-GDH or Ad-lacZ in 1 ml RPMI-1640 medium for 90 min and assayed the next day. Prior to the experiments, cells were maintained for 2 h in glucose-and glutamine-free culture medium. The cells were then washed with Krebs-Ringer bicarbonate Hepes buffer (KRBH) with the following composition (in mmol/l): 135 NaCl, 3.6 KCl, 5 NaHCO 3 , 0.5 NaH 2 PO 4 , 0.5 MgCl 2 , 1.5 CaCl 2 , 10 Hepes, pH 7.4. Next, cells were subjected to 60 min incubation in KRBH with 2.8 or 16.7 mmol/l glucose. The incubation was stopped by putting the plates on ice and washing the cells with ice cold PBS. Cells were then extracted with 35% sulfosalicylic acid for 18 h at 4°C and samples were frozen at −80°C, before amino acid measurements were done by reverse-phase high-pressure liquid chromatography (HPLC) after derivatisation with o-phthalaldehyde [41] .
Mitochondrial membrane potential and ATP generation. INS-1E cells were cultured 2 to 3 days, infected with Ad-GDH or Ad-lacZ for 90 min and used for experiments the next day. Mitochondrial membrane potential (∆Ψ m ) was measured as described [42] using rhodamine-123. Cells were used as a suspension in KRBH buffer and gently stirred in a fluorimeter cuvette at 37°C. Then fluorescence was excited at 490 nm and measured at 530 nm. Cytosolic ATP levels were monitored in cells expressing the ATP-sensitive bioluminescent probe luciferase after infection with the specific viral construct [15, 43] .
Insulin secretion assay. INS-1E cells cultured in 24-well plates were infected over a 90-min period with either Ad-GDH or Ad-LacZ adenovirus and assayed the next day. Prior to the experiments, cells were maintained for 2 hours in glucose-and glutamine-free culture medium. The cells were then washed and preincubated further in glucose-free KRBH, supplemented with 0.1% bovine serum albumin as carrier, before the incubation period (30 min at 37°C) with different glucose concentrations, L-leucine or KCl.
Isolated rat islets were infected with Ad-GDH or Ad-LacZ adenovirus over a 90-min period on the day after isolation and further cultured for 24 h before the secretion assay. Islet perifusions were carried out using 15 to 20 hand-picked islets per chamber of 250 µl volume, thermostatted at 37°C (Brandel, Gaithersburg, Md., USA). The flux was set at 0.5 ml/min and fractions were collected every minute after a 20-min washing period at basal glucose. At the end of the perifusion period islets were taken out of the chamber and acid-EtOH extracts were used to measure the insulin content. Insulin levels were determined by radioimmunoassay using rat insulin as standard [13] . Insulin secretion was expressed as the fraction of insulin collected every minute over total insulin content per corresponding chamber (% content). All compounds tested on insulin secretion were obtained from Sigma-Aldrich (Buchs, Switzerland). The 2-aminobicyclo-[2,2,1]heptane-2-carboxylic acid (BCH) used was a mixture of exo-and endo-isomers.
Cellular metabolism assessed by the MTT assay. The 3-(4,5-dimethylthiazol-2-yl)-2,5,-diphenyl tetrazolium bromide (MTT) assay measures the redox potential of cells through formation of formazans precipitated from tetrazolium salts, and was used as described previously [44, 45] . Briefly, this colorimetric assay measures the reduction of MTT that enters the cells, where MTT is reduced, essentially by mitochondrial dehydrogenases. Isolated rat islets were infected with Ad-GDH or Ad-LacZ adenovirus over a 90-min period on the day after isolation and used the next day. Batches of 40 hand-picked islets were distributed into wells of 96-well plates, pre-incubated for 1 hour in KRBH with 2.8 mmol/l glucose, before adding the indicated stimulation conditions in 100 µl. After 30 min an aliquot of the supernatant was collected for insulin release measurement and the reaction was continued for 90 min in the presence of 0.5 mg/ml MTT (Sigma). Next, formazan precipitates were extracted (20% SDS, 50% DMF) overnight and absorbance recorded at 570 nm.
Statistical analyses.
Where applicable, the results were expressed as means ± SD. Differences between groups were analysed by Student's t test for unpaired data and significance assessed by a p value of less than 0.05.
Results

Assessment of adenovirus-mediated GDH overexpression in INS-1E cells.
Immunoblotting of the prepared cells using anti-bovine GDH antibody revealed a band at the expected size of 54 M r , Ad-LacZ representing expression of endogenous GDH (Fig. 1a) . Using Ad-GDH, GDH was overexpressed in a dose-dependent manner, i.e. 7.4-fold at 0.5 µl, 9.7-fold at 1.0 µl and 13.9-fold at 5.0 µl versus Ad-LacZ, as determined by quantitative densitometry. To test whether this overexpressed protein was functional, GDH activity was measured in cell extracts of transduced INS-1E cells. GDH activity, monitored under the oxidative deamination direction, was no different in INS-1E cells transduced with Ad-LacZ control virus than it was in noninfected cells (Fig. 1b) . Infections with increasing concentrations of the Ad-GDH virus resulted in a dose-dependent increase in GDH enzymatic reaction rates. After infection with 1.0 µl/ml Ad-GDH, immunofluorescence showed mitochondrial localisation of GDH (Fig. 1c,d ), although some cytosolic staining was observed in control and in cells overexpressing GDH. At high Ad-GDH virus concentrations (5.0 µl/ml), stronger cytosolic staining was observed (not shown). Taken together, these data show that functional GDH can be efficiently overexpressed. Consequently a virus concentration of 1.0 µl/ml was selected for the rest of the study.
Mitochondrial membrane potential and ATP generation in INS-1E cells. In control cells transduced with
Ad-LacZ virus, ∆Ψ m was hyperpolarised by raising glucose from basal 2.8 mmol/l to 12.8 mmol/l (Fig. 2a) . Further addition of the protonophore FCCP (carbonyl cyanide p-trifluoromethoxyphenylhydrazone) resulted in a rapid depolarisation, reflecting dissipation of the proton gradient. Similar effects were seen in cells overexpressing GDH. In accordance with ∆Ψ m , ATP generation, monitored in cells expressing luciferase, was not affected by GDH overexpression (Fig. 2b) . Indeed, raising glucose from 2.8 to 12.8 mmol/l increased cytosolic ATP levels to similar extents in Ad-LacZ and Ad-GDH groups, i.e. 145±13% versus 142±9% of basal values (n=5 independent experiments). Therefore, GDH overexpression does not modify glucose-mediated activation of the electron transport chain (judged here as ∆Ψ m ) or ATP generation. (Table 1) . In control cells, two amino acids were increased by high glucose, i.e. alanine (4.8-fold, p<0.01) and glutamate (2.8-fold, p<0.01). Conversely, aspartate and γ-aminobutyric acid (GABA) were decreased under the same conditions (−65%, p<0.01 and −23%, p<0.05 respectively). In INS-1E cells overexpressing GDH only glutamate was increased (3.4-fold, p<0.01) and aspartate lowered (−69%, p<0.05) at 16.7 mmol/l glucose compared with basal 2.8 mmol/l glucose. Finally, GABA, which is a decarboxylation product of glutamate, was decreased by GDH overexpression compared with the corresponding Ad-LacZ group at 16.7 mmol/l glucose (−31%, p<0.05). glutamate dehydrogenase (GDH) was overexpressed in a dosedependent manner in Ad-GDH-infected cells. GDH activity (b) was monitored in cell extracts under the oxidative deamination direction as NADH fluorescence. The reaction was started by adding 1 mmol/l glutamate (Glu) and 20 min later purified bovine GDH was added as positive control. Cellular localization of GDH in the cells transduced with Ad-GDH was investigated the day after infection. Mitochondrial staining was done using the dye mitotracker (c) and GDH was revealed by immunofluorescence using anti-GDH antibody (d). Observations are representative of five to six independent experiments Insulin secretion was also stimulated at basal 2.5 mmol/l glucose with 30 mmol/l KCl, used as a Ca 2+ raising agent as a consequence of membrane depolarisation and opening of voltage-gated Ca 2+ channels (Fig. 3) . In control cells (Ad-LacZ), stepwise increases of glucose from basal 2.5 mmol/l to 20 mmol/l led to a dose-dependent stimulation of insulin release (up to 5.9-fold at 20 mmol/l glucose, p<0.001 vs basal). Leucine is both a mitochondrial substrate and an allosteric activator of GDH. At 2.5 mmol/l glucose, 20 mmol/l L-leucine evoked a 3.2-fold (p<0.005) secretory response, which was further increased at 7.5 mmol/l glucose (6.3-fold, p<0.001), indicating an additive effect of the amino acid on the sugar. Overexpression of GDH did not modify basal insulin release, whereas at 15 and 20 mmol/l glucose the secretory responses were 31% (p<0.05) and 25% (p<0.05) greater respectively, compared with corresponding glucose-matched controls. The combined effects of 7.5 mmol/l glucose plus 20 mmol/l L-leucine were potentiated by GDH overexpression (22% higher, p<0.05). Non-nutrient induced insulin secretion, by exposure to depolarising concentrations of KCl, resulted in similar stimulations in the Ad-LacZ and Ad-GDH groups (3.9-fold and 4.1-fold respectively). These data show that GDH overexpression in INS-1E cells specifically potentiates optimal nutrient-evoked insulin secretion.
Amino acid levels in INS-1E cells overexpressing GDH. Several amino acids were measured by HPLC in INS-1E cells transduced with corresponding viruses
GDH overexpression and insulin secretion in rat and mouse islets.
Immunoblotting of the prepared islets (Fig. 4a) confirmed that rat islets express higher levels GABA, γ-aminobutyric acid Fig. 3 . Insulin secretion in INS-1E cells overexpressing glutamate dehydrogenase (GDH). The cells were infected for a 90 min with Ad-GDH or Ad-LacZ adenovirus and analysed the next day. After preincubation and rinsing in glucose-free buffer, cells were challenged for 30 min with: 2.5, 7.5, 15 and 20 mmol/l glucose; 20 mmol/l L-leucine (at 2.5 or 7.5 mmol/l glucose); and 30 mmol/l KCl (at 2.5 mmol/l glucose). Observations are representative of 3 to 6 independent experiments. *p<0.05, **p<0.01 and ***p<0.001 vs basal glucose; § p<0.05 vs Ad-LacZ at corresponding glucose concentrations (4.1-fold) of endogenous GDH than mouse islets and showed efficient overexpression of GDH following virus infection. Controls of enhanced enzymatic activity were also done as described for INS-1E cells in Fig. 1b .
Rat islets transduced with control Ad-LacZ virus responded to glucose stimulation by a sustained increase in rate of insulin secretion at 8.3 mmol/l glucose, further enhanced at 16.7 mmol/l glucose (Fig. 4b) . Overexpression of GDH had no significant effects at basal (2.8 mmol/l) or intermediate (8.3 mmol/l) glucose concentrations. In contrast, at 16.7 mmol/l glucose the secretory response was 35% greater in islets overexpressing GDH than in controls [area under the curve (AUC) =11.50±1.28 vs 8.53±0.93 respectively (insulin release as % content), p<0.05]. These results are consistent with those obtained in the clonal beta-cell line INS-1E, i.e. potentiation at high but not at basal or intermediate glucose concentrations.
In mouse islets transduced with control Ad-LacZ virus we saw a right-shift of the glucose dose response compared with that of rat islets (Fig. 4c) . At 7.5 mmol/l glucose there was no significant secretory response, but there was sustained sub-optimal stimulation at 15 mmol/l (AUC=0.75±0.52 and 6.03±1.23 respectively), and strong insulin release at 25 mmol/l glucose (AUC=8.97±0.51) (see below). GDH overexpression did not modify glucose-stimulated insulin release in mouse islets.
Next, we tested the potential of optimised GDH activity in islets overexpressing GDH. Therefore, the L-leucine non-metabolisable analogue BCH was supplemented as an allosteric activator of GDH. At 8.3 mmol/l glucose, control rat islets responded to 10 mmol/l BCH with a 2.7-fold (p<0.001) rise in insulin secretion (Fig. 5a ). Islets overexpressing GDH further raised their secretory response by 36% versus controls (AUC=8.19±0.71 vs 6.01±0.40, p<0.05). Upon stepwise increases of glucose, insulin secretion profiles showed sustained monophasic kinetics (Fig. 4b) . In contrast, the secretory response was biphasic when switching directly from basal 2.8 to high 16.7 mmol/l glucose (Fig. 5b) . Interestingly in these conditions, the potentiating effect of GDH overexpression was specific for the second phase (AUC: +54%, p<0.05 vs Ad-LacZ). In Ad-GDH islets, addition of BCH at 16.7 mmol/l glucose did not further modify the prominent rate of insulin release, which in that case was also reached by control Ad-LacZ islets (AUC=7.54±0.51 vs 6.77±0.33 respectively, p<0.05). The insulin content of islets collected from the perifusion chambers at the end of the experiment was similar in Ad-LacZ and Ad-GDH groups (21.7±2.8 vs 20.0±2.3 ng/islet respectively).
In mouse islets, the addition of 10 mmol/l BCH at 25 mmol/l glucose (Fig. 6a) further raised insulin secretion by 39% (p<0.05). The latter condition was potentiated by 43% in islets overexpressing GDH compared with the Ad-LacZ group (AUC=17.9±2.6 vs 12.5±2.0 respectively, p<0.05). Islet insulin contents at the end of the experiment were similar in the AdLacZ and Ad-GDH groups (23.7±4.8 vs 28.8±16.9 ng/ islet respectively). Fig. 4a, b . Effect of glutamate dehydrogenase (GDH) overexpression on glucose-stimulated insulin secretion in rat and mouse islets. Isolated rat or mouse islets were infected with Ad-GDH or Ad-LacZ adenovirus for 90 min on the day after isolation and further cultured for 24 h before secretion assay. Islet perifusions were done using 20 islets per chamber at 0.5 ml/min and fractions were collected every minute. Control of GDH overexpression by immunoblotting (a) in rat and mouse pancreatic islets. Rat islets (b): after a period at basal 2.8 mmol/l glucose, insulin secretion was stimulated by raising glucose from 2.8 to 8.3 mmol/l for 15 min, directly followed by 15 min at 16.7 mmol/l glucose, then returning to 2.8 mmol/l. Mouse islets (c): glucose was raised from 2.5 to 7.5 mmol/l for 15 min before stimulation by 15 mmol/l glucose for the next 15 min. Values are means ± SD (n=4 per group) of one out of three independent experiments. Calculation of the areas under the curves and corresponding statistics are given in the Results section. *p<0.05 vs Ad-LacZ for corresponding time points lease, unless specific conditions are applied such as addition of BCH as an activator of GDH. Accordingly, at basal glucose (Fig. 6b) , control mouse islets did not respond to 5 mmol/l glutamine before adding 10 mmol/l BCH, which then resulted in a 14.5-fold increase of insulin release (AUC=1.1±1.5 vs 16.6±0.2 respectively, p<0.005). Similarly, rat islets (Fig. 7a) responded to glutamine only in the presence of BCH, although the stimulation was weaker than in mouse islets (2.5-fold, p<0.05). When BCH was added before glutamine exposure, it triggered transient insulin secretion (2.3-fold, p<0.005) (Fig. 7b) , possibly due to an endogenous pool of glutamine and/or glutamate in rat islets sufficient to stimulate secretion. Rat islets transduced with Ad-GDH were made responsive to glutamine, showing a 2.7-fold increase in insulin release compared with Ad-LacZ islets (AUC=4.50±0.59 vs 1.69±0.50 respectively, p<0.05) (Fig. 7a) . Further supplementation with BCH increased the secretory response in islets overexpressing GDH in comparison with controls (2.2-fold, p<0.05). Similar results were obtained when the sequence of additions was reversed (first BCH, then glutamine; Fig. 7b) , with a 3.5-fold potentiation of insulin release associated with GDH overexpression compared to controls (p<0.05). In mouse islets, GDH overexpression did not change the secretory responses to glutamine with or without BCH (Fig. 6b) .
GDH overexpression and glutamine-induced insulin secretion. Glutamine alone does not trigger insulin re-
Glutamine can be turned into a secretagogue by BCH through enhanced glutamine oxidation. In the MTT assay, used to measure islet cell metabolism associated with glutamine exposure (Fig. 8a) , we found that 5 mmol/l glutamine failed to promote cell metab- Fig. 5a , b. Effect of (+/−)-2-aminobicyclo-[2,2,1]heptane-2-carboxylic acid (BCH) on glucose-stimulated rat islets overexpressing glutamate dehydrogenase (GDH). Isolated rat islets were infected with Ad-GDH or Ad-LacZ adenovirus the day after isolation and used the next day. Islets (a) were first stimulated with 8.3 mmol/l glucose for 15 min before adding 10 mmol/l BCH for another 15 min. After 15 min exposure at 16.7 mmol/l glucose (b), 10 mmol/l BCH were added for the next 15 min. Values are means ± SD (n=4 per group) of one out of three independent experiments. For calculation of the areas under the curves and corresponding statistics, see Results section. *p<0.05 vs Ad-LacZ for corresponding time points Fig. 6a, b . Effect of glutamate dehydrogenase (GDH) overexpression and activation on insulin secretion in mouse islets. Isolated mouse islets were infected with Ad-GDH or Ad-LacZ adenovirus for 90 min on the day after isolation and further cultured for 24 h before secretion assay. After a period (a) at basal 2.5 mmol/l glucose, insulin secretion was stimulated by raising glucose to 25 mmol/l for 15 min, followed by 15 min with glucose (25 mmol/l) and 10 mmol/l (+/−)-2-aminobicyclo-[2,2,1]heptane-2-carboxylic acid (BCH), then returning to 2.5 mmol/l glucose. After a 15-min exposure (b) to 5 mmol/l glutamine, 10 mmol/l BCH was added for the next 15 min. Values are means ± SD (n=4 per group) of one out of three independent experiments. For calculation of the areas under the curves and corresponding statistics, see Results section. *p<0.05 vs Ad-LacZ for corresponding time points olism in control rat islets, unless 10 mmol/l BCH were added (42% increase, p<0.05 vs basal 2.8 mmol/l glucose conditions). In contrast, glutamine alone induced cell metabolism in islets overexpressing GDH (62% higher, p<0.01 vs control islets), and this was further enhanced by adding BCH. All these metabolic events correlated with insulin secretion (Fig. 8b) . Therefore, modulations of GDH expression and/or activity determine glutamine metabolism and associated secretory responses.
Discussion
In our study GDH was overexpressed in the beta cell line INS-1E as well as in rat and mouse pancreatic islets. Pancreatic beta cells have remarkably high anaplerotic activity [46, 47] as a likely compensatory mechanism for important cataplerosis, i.e. leak out of the TCA cycle. GDH is one of the major cataplerotic enzymes [48] and can form glutamate from the TCA cycle intermediate, α-ketoglutarate. Downstream of mitochondrial activation, glutamate might play a role in exocytosis, together with permissive cytosolic Ca 2+ levels, by acting on secretory granules [13, 17, 49, 50] . Principally, GDH is also considered important for its anaplerotic function, mediating deamination of glutamate to α-ketoglutarate [51] . Therefore, in pancreatic beta cells, the preferred directional flux of the enzyme is still under discussion [16, 29, 30, 31, 52] , depending both on stimulation conditions and allosteric regulation.
Adenovirus-mediated overexpression of GDH potentiated the secretory responses evoked by high glucose without any effects at low glucose. This is consistent with a previous study, which was done with INS-1E cells by transient transfection of GDH cDNA and showed enhanced secretory responses to high glucose, measured as the release of human growth hormone, which is used as a reporter of efficiently transfected cells [53] . In that study, the combination of GDH overexpression with intermediate glucose concentrations and allosteric activation of GDH resulted in major rates of insulin release. At high glucose concentrations, GDH overexpression was also associated with potentiation of the secretory response in INS-1E cells and rat islets. In mouse islets, such potentiation was restricted to the combined effects of high glucose plus BCH (an activator of GDH). As basal GDH expression levels are lower in mouse than in rat islets [39] , our unexpected results suggest that there is a species specificity in GDH-related metabolism. Interestingly, the effects of GDH overexpression were specific for the second phase of the secretory response, indicating that GDH exerts its principal effect in the sustained phase of insulin release. These results show that normal GDH expression levels in islets are sufficient for intermediate glucose-evoked insulin release, but are rate-limiting for optimal secretory responses to high glucose. Unlike glucose, glutamine poorly stimulates mitochondrial metabolism under normal conditions and as a result, ATP production is only weak in islets with such a stimulus [24, 25, 54] . Consequently, ATP generation is probably not sufficient to depolarise the plasma membrane through closure of ATP-sensitive K + channels, a process which is required for cytosolic Ca 2+ increase. Therefore, islet glutamate levels can be markedly increased by exposure to extracellular glutamine and, because of scarce conversion of glutamate to α-ketoglutarate [24] , without stimulation of insulin secretion [24, 55] . Activation of GDH by L-leucine or its non-metabolisable analogue BCH increases glutamine oxidation and insulin secretion, essentially by enhancing the oxidative deamination of glutamate [25, 27, 28, 29, 32, 33, 56] . GDH activity is under the tight control of allosteric effectors, although the flux direction depends chiefly on the relative supply of substrates and cofactors, i.e. glutamate, α-ketoglutarate, and NAD(P) + /H respectively. Accordingly, glutamine oxidation stimulated by the presence of an allosteric activator of GDH is inhibited by glucose [28] , which increases the carbon pool on the TCA cycle side. The glutamate and α-ke toglutarate pathway is operated either by GDH or alternatively by transamination reactions [57, 58] . In the latter case, aspartate conversion to oxaloacetate serves as the ammonium donor for α-ketoglutarate, resulting in the formation of glutamate. From the present data, one cannot precisely assess the relative contributions of GDH and transamination reactions. However, upon glucose stimulation in INS-1E cells, increased glutamate was associated with a decrease in aspartate. Moreover, GDH overexpression did not modify the glucose-induced increase in cellular glutamate concentrations. It has been shown by NMR spectroscopy in beta-cell lines that glutamate is a major product of glucose metabolism [31, 59] . Taken together, these results indicate a prominent contribution of transamination reactions in the generation of glutamate under glucose stimulation, in accordance with a recent report [60] .
After glutamine exposure, the glutamate thus formed is increased but poorly converted to TCA cycle intermediates unless BCH (or L-leucine) allosterically activates GDH, thereby promoting mitochondrial activation and ATP generation. Such effects were observed in the present study when glutamine enhanced cellular metabolism in rat islets exposed to BCH, correlating with stimulation of insulin secretion. Remarkably, overexpression of GDH was sufficient to turn glutamine into an effective secretagogue together with metabolism induction. Combined GDH overexpression with its activation by BCH further potentiated the secretory responses evoked by glutamine. Thus, it is shown here that tight control of insulin secretion can be altered when the activity of the key enzyme GDH is modified with profound alterations of secretory responses. Expression of mutant GDH, which is associated with unregulated increased GDH activity and hyperinsulinism syndrome [8] , has been recently examined in a beta-cell line [61] . Expression of the activating mutation was associated with glutamine-evoked insulin secretion, whereas glucose dose response was left-shifted [61] . Together these data show that in beta cells, under physiological conditions, GDH prevents the potential secretagogue function of glutamine and could be rate limiting for that of glucose. The lack of secretory response to glutamine could result from defective ATP generation.
Glutamine is the most abundant amino acid in muscle and plasma [62] . Accordingly, muscle is an important reservoir from which the glutamine pool can be mobilised during acute exercise [63] . Moreover, following an overnight fast, there is a net release of amino acids from skeletal muscle, glutamine being quantitatively most prominent [48] . Acute exercise as well as an overnight fast are both physiological states in which insulin secretion must be avoided. This is consistent with the low expression of monocarboxylate transporter in beta cells, which avoids pyruvate and lactate-induced insulin release [64] . Clinical significance of such undesired secretory responses has recently been reported in the form of an autosomal trait characterised by abnormal pyruvate-induced insulin release and exercise-induced hyperinsulinaemic hypoglycaemia [65] . We conclude that GDH could play a key role in beta cells as a gatekeeper to prevent amino acids, in particular glutamine, from being effective secretagogues.
